|
|
||||||||
Published online before print July 6, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
,
@
*University of Iowa Hospitals and Clinics & VAMC Iowa City, Department of Internal Medicine;
Gemini Sciences Inc., San Diego, California; and
Immunology Graduate Program University of Iowa, Iowa City
@ To whom correspondence should be addressed. E-mail: nicholas-zavazava{at}uiowa.edu.
| Abstract |
|---|
Monomeric and dimeric soluble major histocompatibility complex (MHC) molecules down-regulate activated T cells in an antigen-specific manner in vitro. This property could be exploited to modulate alloresponses in vivo but has remained difficult to demonstrate. Here, intraperitoneal infusion of a Lewis-derived rat MHC class I molecule, RT1.Al-Fc, in Dark Agouti (RT1.Aa) recipient rats prolonged cardiac graft survival, which led to permanent engraftment. This effect was mediated by T cell impairment of target cell lysis by CD8+ T cells and down-regulation of interferon-
production by CD4+ T cells. The binding of the dimeric MHC allowed ex vivo visualization of alloreactive T cells in peripheral blood, splenocytes, and allografts, revealing low frequency of alloreactive CD8+ T cells after establishment of permanent engraftment of cardiac allografts. Thus, these data show the potential of dimeric MHC molecules to promote graft survival and allow visualization of alloreactive T cells.
Key Words: transplantation tolerance concanavalin A FLAG
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |